CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-06 | Holsinger Leslie Executive Vice President | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-02-06 | LOWE CHRISTOPHER P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-02-06 | Lynch Casey Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2020-01-29 | EPIQ Capital Group, LLC IA/Managing Member of 10% Owne | Other disposition | −4,338 | $54.30 | $236K | 2,843,237 |
| 2019-08-21 | EPIQ Capital Group, LLC IA/Managing Member of 10% owne | Purchase | +420 | $24.87 | $10K | 2,845,940 |
| 2019-08-21 | EPIQ Capital Group, LLC IA/Managing Member of 10% owne | Purchase | +1,635 | $24.87 | $41K | 2,847,575 |
| 2019-08-21 | EPIQ Capital Group, LLC IA/Managing Member 10% owner | Purchase | +420 | $24.87 | $10K | 2,832,926 |
| 2019-08-21 | EPIQ Capital Group, LLC IA/Managing Member 10% owner | Purchase | +1,635 | $24.87 | $41K | 2,834,561 |
| 2019-08-20 | EPIQ Capital Group, LLC IA/Managing Member of 10% owne | Purchase | +600 | $25.69 | $15K | 2,843,210 |
| 2019-08-20 | EPIQ Capital Group, LLC IA/Managing Member of 10% owne | Purchase | +2,310 | $25.69 | $59K | 2,845,520 |
| 2019-08-20 | EPIQ Capital Group, LLC IA/Managing Member 10% owner | Purchase | +600 | $25.69 | $15K | 2,830,196 |
| 2019-08-20 | EPIQ Capital Group, LLC IA/Managing Member 10% owner | Purchase | +2,310 | $25.69 | $59K | 2,832,506 |
| 2019-08-19 | EPIQ Capital Group, LLC IA/Managing Member of 10% owne | Purchase | +2,100 | $26.50 | $56K | 2,842,610 |
| 2019-08-19 | EPIQ Capital Group, LLC IA/Managing Member 10% owner | Purchase | +2,100 | $26.50 | $56K | 2,829,596 |
| 2019-08-16 | EPIQ Capital Group, LLC IA/Managing Member of 10% owne | Purchase | +700 | $26.37 | $18K | 2,840,510 |
| 2019-08-16 | EPIQ Capital Group, LLC IA/Managing Member 10% owner | Purchase | +700 | $26.37 | $18K | 2,827,496 |
| 2019-08-15 | Gafric Kristen SVP, Legal & Administration | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-05-13 | YOUNG KEVIN Director | Purchase | +30,000 | $17.00 | $510K | 30,000 |
| 2019-05-13 | RYAN UNA S Director | Purchase | +2,875 | $17.00 | $49K | 2,875 |
| 2019-05-13 | McLoughlin Margaret Director | Purchase | +550 | $17.00 | $9K | 550 |
Page 16 of 18 · 350 trades